693
Views
10
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature

, , , , , , , , , , , , , , & show all
Pages 2289-2297 | Received 05 Nov 2015, Accepted 09 Jan 2016, Published online: 08 Feb 2016

References

  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: Internation Agency for Research Cancer (IARC); 2007.
  • Borkhardt A, Wuchter C, Viehmann S, et al. Infant acute lymphoblastic leukemia-combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia. 2002;16:1685–1690.
  • Tsao L, Draoua HY, Osunkwo I, et al. Mature B-cell acute lymphoblastic leukemia with t(9;11) translocation: a distinct subset of B-cell acute lymphoblastic leukemia. Mod Pathol. 2004;17:832–839.
  • Frater J, Batanian J, ÓConnor D, et al. Lymphoblastic leukemia with mature B cell phenotype in infancy. J Pediatr Hematol Oncol. 2004;26:672–677.
  • Blin N, Mechinaud F, Talmant P, et al. Mature B-cell lymphoblastic leukemia with MLL rearrangement: an uncommon and distinct subset of childhood acute leukemia. Leukemia. 2008;22:1056–1059.
  • Behm FG, Head DR, Pui CH, et al. B precursor ALL with unexpected expression of surface immunoglobulin (Sig) Mu and Lambda (abstract). Lab Invest. 1995;72:106A.
  • Lorenzana AN, Rubin CM, Le Beau MM, et al. Immuno-globulin gene rearrangements in ALL with the 9;11 translocation. Genes Chromosomes Cancer 1991;1:74–77.
  • Li S, Lew G. Is B-lineage ALL with a mature phenotype and L1 morphology a precursor B lymphoblastic leukemia-lymphoma or Burkitt leukemia-lymphoma? Arch Pathol Lab Med. 2003;127:1340–1344.
  • Hsi (abstract) Society of Hematopathology/European Association of Hematopathology Workshop-Pediatrichematopathology cases.
  • Lorsbach (abstract) Society of Hematopathology/European Association of Hematopathology Workshop-Pediatric Hematopathology Cases.
  • Lim L, Chen KS, Krishnan S, et al. Mature B-cell acute lymphoblastic leukaemia associated with a rare MLL-FOXO4 fusion gene. Br J Haematol. 2012;157:651.
  • Shaffer LG, McGowan-Jordan J, Schmid M, editors. ISCN2013: an international system for human cytogenetic nomenclature. Basel: Karger; 2013.
  • van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901–1928.
  • Alonso CN, Gallego MS, Rossi JG, et al. RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina. Leuk Res. 2012;36:704–708.
  • Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370:240–250.
  • Lisfeld J, Burkhardt B, Zimmermann M, et al. CNS disease in pediatric patients with B cell non-Hodgkin lymphoma and Burkitt leukemia-therapy and outcome in the B-NHL BFM 04 study. Hematol Oncol. 2013;31:122.
  • Meyer C, Hofmann J, Burmeister T, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013;27:2165–2176.
  • Chessells J, Harrison C, Watson S, et al. Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999. Br J Haematol. 2002;117:306–314.
  • Atarbaschi A, Mann G, Konig M, et al. Mixed lineage leukemia rearranged childhood Pro-B and CD10 negative Pre-B acute lymphoblastic leukemia constitute a distinct clinical entity. Clin Cancer Res. 2006;12:2988–2994.
  • Bertram F, Voghtenhuber C, Shah N, et al. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein. Blood. 2001;98:3398–3405.
  • Rossi J, Bernasconi A, Alonso C, et al. Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am J Hematol. 2012;87:890–897.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.